Journal of cardiovascular disease research Impact Factor & Information

Publisher: Medknow Publications

Journal description

Current impact factor: 0.00

Impact Factor Rankings

Additional details

5-year impact 0.00
Cited half-life 0.00
Immediacy index 0.00
Eigenfactor 0.00
Article influence 0.00
ISSN 0976-2833

Publisher details

Medknow Publications

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Non-commercial
    • Publisher's version/PDF may be used
    • Creative Commons Attribution Non-Commercial Share Alike License
    • Published source must be acknowledged
    • All titles are open access journals
  • Classification
    ​ green

Publications in this journal

  • Source
    Journal of cardiovascular disease research 11/2014; 5(3). DOI:10.5530/jcdr.2014.3.7
  • Source
    Journal of cardiovascular disease research 11/2014; 5(3). DOI:10.5530/jcdr.2014.3.3
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to compare the performance of nurses and medical staff in using two methods of hemodynamic monitoring in cardiac surgery patients. We designed a double-blind study in which nurses and physicians measured cardiac output and other hemodynamic variables using pulmonary artery catheter thermodilution (PACTD; the ‘gold standard’) and a comparator (continuous cardiac dynamic monitoring [CCDM]-HeartSmart®). Hemodynamic values measured using PACTD and HeartSmart® were comparable between nurses and physicians. In addition, PACTD measurements were in good agreement with those derived from CCDM-HeartSmart®. Specialized Cardiac Intensive Care Unit (CICU) nurses are as competent as any member of the medical staff in measuring hemodynamic measurements using PACTD
    Journal of cardiovascular disease research 04/2014; 2(2).
  • [Show abstract] [Hide abstract]
    ABSTRACT: Case Study
    Journal of cardiovascular disease research 03/2014; 2329(2):2.
  • [Show abstract] [Hide abstract]
    ABSTRACT: a b s t r a c t Background: A wide variation exists in the patterns of pharmacotherapy among patients admitted with cardiovascular diseases. Very few studies have evaluated the potential determinants of drug utilization. Our objective was to evaluate the clinical characteristics and patterns of cardiovascular drug utilization among patients in coronary care unit (CCU) and assess the determinants of cardiovascular drug use among patients with coronary artery disease (CAD). Methods: In this retrospective cohort study, the medical records of CCU patients were reviewed independently by two trained physicians over one year. Patients were analyzed as two groups e those with CAD and without CAD. Multivariate logistic regression was done to identify the determinants of cardiovascular drug utilization in the CAD group. Results: Of 574 patients, 65% were males, 57% were <60 years. The five commonly prescribed drug classes were platelet inhibitors (88.7%), statins (76.3%), ACE-inhibitors/Angiotensin receptor blockers (72%), beta-blockers (58%) and heparin (57%). Poly-pharmacy (>5 drugs) was noticed in 71% of patients. A majority of patients had diagnosis of CAD (72.6%). CAD patients received significantly higher median number of drugs and had longer duration of CCU stay (p < 0.0001). Renal dysfunction for ACE-inhibitors [0.18 (0.09e0.36)], ST-elevation myocardial infarction for calcium channel blockers [0.29 (0.09e0.93)] and brady-arrhythmias for beta-blockers [0.3 (0.2e0.7)] were identified as determinants of decreased drug use in CAD group. Conclusion: Predominance of male gender, age <60 and poly-pharmacy was observed in CCU. Antithrombotics, statins, ACE-inhibitors/Angiotensin receptor blockers and beta-blockers were the most frequently prescribed drugs. Clinical co-morbidities (renal dysfunction, arrhythmias) decreased the utilization of ACE-inhibitors, beta-blockers among CAD patients. Copyright � 2013, SciBioIMed.Org, Published by Reed Elsevier India Pvt. Ltd. All rights reserved.
    Journal of cardiovascular disease research 02/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Acute myocardial infarction (AMI) concomitant with aortic dissection (AD) is rare but a devastating situation if misdiagnosed as simply AMI, followed by anticoagulant or thrombolytic therapy. In such cases, Standford type B AD was extremely infrequent. Objectives To present a case with apparent concordance with the patient's history, symptoms, cardiac enzymes that lead to diagnostic error. Case report An 85-year-old man with chronic hypertension and coronary atherosclerotic heart disease presented in our emergency department with squeezing retrosternal chest pain and dyspnea. Elevated cardiac enzymes and electrocardiography result suggested acute non-ST-segment elevation myocardial infarction. Emergency coronary angiography demonstrated a 50–90% diffuse stenosis of the proximal and mid right coronary artery also confirmed the diagnosis. Stents were deployed thereafter. However, the patient was found to be concomitant with Standford type B AD by computed tomography angiography due to unrelieved chest pain and new onset of abdominal pain after the operation. The patient refused to have endovascular operation and died of hemorrhagic shock one week later. Conclusions AD may cause AMI due to some indirect mechanisms, and it is of utmost importance to search for the existence of AD before reperfusion therapy in AMI patients. Aortic dissection detection risk score, transthoracic echocardiography and D-dimer help early identification of AD.
    Journal of cardiovascular disease research 02/2014; DOI:10.1016/j.jcdr.2013.12.002